The labor board determined that Amazon Canada Fulfillment Services ULC violated provincial labor laws by interfering with ...

According to two Canadian government officials cited by Politico, Ottawa will no longer proceed with plans to double its ...

U.S. copper imports are set to plunge in the coming months as a wave of front-loaded shipments leaves the country with excess ...

When you’ve accumulated more than $1 million for retirement, your financial priorities shift. It’s no longer just about growth but about protecting what you’ve built and generating reliable income ...

So, the latest episode in the never-ending US tax and tariff saga has given the impression that ‘extend and pretend’ is now also a favourite theme in Washington. But I wouldn’t be so sure. The heat is ...

Investing.com- President Donald Trump’s “big beautiful bill” has been hailed as the fiscal shot in the arm that could restore U.S. economic exceptionalism. But as the ink dries on this transformative ...

Investing.com -- India’s Aircraft Accident Investigation Bureau released a preliminary report Friday on the Air India Flight 171 crash that occurred in Ahmedabad on June 12, revealing that one of the ...

Investing.com -- Ultragenyx Pharmaceutical (TADAWUL: 2070) Inc. (NASDAQ: RARE) stock fell over 5% after the company announced that the U.S. Food and Drug Administration (FDA) has issued a Complete ...

Investing.com -- President Trump issued an order today blocking the acquisition of Jupiter Systems by Suirui International Co., Limited, a Hong Kong company majority-owned by China’s Suirui Group Co., ...

Investing.com -- Alberta Investment Management Corporation (AIMCo) has named Justin Lord as its new Chief Investment Officer, effective immediately, following an extensive international search.

Investing.com -- New tariffs announced by President Trump have complicated the inflation outlook, making it harder for Chicago Fed President Austan Goolsbee to support interest rate cuts that the ...

The published data showed that the combination of avutometinib plus defactinib demonstrated a confirmed overall response rate of 31% in all patients with recurrent low-grade serous ovarian cancer ...